Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL
Clinical trial NCT05557903 · UNKNOWN
Trial details
- NCT number
- NCT05557903
- Sponsor
- Lanzhou Institute of Biological Products Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-20
- Primary completion
- 2022-12-30
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.